Signaling Pathways
-
B4887 Remodelin hydrobromideTarget: NAT10Summary: NAT10 inhibitor -
B4888 Obeticholic Acid2 CitationTarget: Farnesoid X receptors (FXRs)Summary: FXR agonist with anticholeretic activity -
B4889 Verdinexor (KPT-335)Summary: XPO1/CRM1 inhibitor -
B4799 Telaglenastat1 CitationTarget: GlutaminasesSummary: Orally active glutaminase inhibitor -
B4800 DefactinibTarget: FAKSummary: FAK phosphorylation inhibitor -
B4803 PEAQXSummary: NMDA antagonist -
B4807 FirocoxibSummary: COX2 inhibitor -
B4808 RG7090Summary: negative modulator of mGluR5 -
B4809 K-115Summary: Selective Rho kinase inhibitor -
B4811 AfuresertibSummary: pan-AKT inhibitor

